Cancer Alpha Preprint Drops: A Bold, AI-Driven Breakthrough in Cancer Diagnostics

Lexington, KY - July 26, 2025 - In what is being hailed as a potential AlphaFold moment for cancer, scientists have released the first production-ready, transformer-based AI platform for precision oncology: Cancer Alpha. The new system, detailed in a preprint on bioRxiv, combines six types of genomic and clinical data to achieve real-time, 99.5% accurate cancer classification - and it's fully explainable, scalable, and ready to deploy.

Developed by Dr. R. Craig Stillwell, Cancer Alpha marks a turning point in AI for medicine: a tool not just built for academic benchmarks, but for hospital integration, diagnostics, and regulatory-grade transparency.

"This isn't just a model - it's a full-stack system. One that thinks like a doctor, processes like a lab, and explains itself like a scientist," said Dr. Stillwell. "We built Cancer Alpha to save lives - not just publish papers."

🔬 Technology Highlights:
• Multi-modal AI: Integrates RNA-seq, methylation, mutations, protein, copy number, and clinical data
• Transformer-powered: Custom architecture fusing TabTransformer and Perceiver IO
• Clinically explainable: SHAP values + attention maps
• Sub-50ms inference: Real-time predictions
• 99.5% classification accuracy across 8 cancer types
• Patent-pending: US Provisional 63/847,316
• Full deployment stack: API (FastAPI), UI (React), Docker + Kubernetes, Streamlit demo

🧠 Why This Matters

Cancer Alpha is the first truly end-to-end system combining modern AI with real-world cancer genomics. It doesn't just outperform traditional diagnostics - it does so with full transparency, making it one of the most clinically viable AI systems in existence.

And it's open to the world:
🔗 https://github.com/rstil2/cancer-alpha

📢 The Team Is Seeking:
• 📈 Commercial and licensing partners
• 🧪 Hospital and research collaborators
• 💰 Investment and biotech partnerships
• 📰 Media coverage and scientific journalism

Contact:
📧 Dr. R. Craig Stillwell
craig.stillwell@gmail.com
https://github.com/rstil2/cancer-alpha

R. Craig Stillwell
649 Ball Hollow Rd.
Hodgenville, KY 42748

🧬 About the Author:

Dr. Stillwell is a computational biologist and former national data lead for the U.S. COVID-19 Test Kit Mission, now focused on building transformative AI tools for medicine. Cancer Alpha is the culmination of 20+ years of work in genomics, machine learning, and translational research.

This release was published on openPR.